News | September 28, 2021
Bal Pharma ramps up API capacity of Gliclazide
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
_256_384.jpg)
The focus of this year’s challenge is to find solutions within Covid management and treatment of cardiovascular, renal, neuro, cancer and lung diseases
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
This deal makes Meddo, one of the largest health-tech players in India
Shilpa's Paracetamol oral thin films are patent protected and are first of this kind in the world
The study was conducted in patients with mild to moderate COVID-19
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Subscribe To Our Newsletter & Stay Updated
